BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19325033)

  • 1. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
    Zhu J; Mactutus CF; Wallace DR; Booze RM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
    Midde NM; Gomez AM; Zhu J
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
    Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG
    J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons.
    Aksenov MY; Aksenova MV; Silvers JM; Mactutus CF; Booze RM
    Neurotoxicology; 2008 Nov; 29(6):971-7. PubMed ID: 18606182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
    Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
    Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.
    Price DA; Sorkin A; Zahniser NR
    Mol Pharmacol; 2009 Oct; 76(4):812-23. PubMed ID: 19628755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.
    Rothman RB; Ananthan S; Partilla JS; Saini SK; Moukha-Chafiq O; Pathak V; Baumann MH
    J Pharmacol Exp Ther; 2015 Jun; 353(3):529-38. PubMed ID: 25788711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
    Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
    Midde NM; Yuan Y; Quizon PM; Sun WL; Huang X; Zhan CG; Zhu J
    J Neuroimmune Pharmacol; 2015 Mar; 10(1):122-35. PubMed ID: 25604666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
    Dutta AK; Xu C; Reith ME
    J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
    Valchar M; Hanbauer I
    J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.
    Kopajtic TA; Liu Y; Surratt CK; Donovan DM; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2010 Dec; 335(3):703-14. PubMed ID: 20855444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.
    Richfield EK
    Mol Pharmacol; 1993 Jan; 43(1):100-8. PubMed ID: 8423763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]WIN 35,428 [2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane] binding to rat brain membranes. Comparing dopamine cell body areas with nerve terminal regions.
    Chen NH; Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1996 Feb; 51(4):563-6. PubMed ID: 8619903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [3H]WIN 35,428 binding.
    Xu C; Coffey LL; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):64-73. PubMed ID: 9007844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
    Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
    J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells.
    Page G; Chalon S; Emond P; Maloteaux JM; Hermans E
    Neurochem Int; 2002 Feb; 40(2):105-13. PubMed ID: 11738476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.